Metalloinvest Opens Its Green Metallurgy Enterprises to Tourists
MOSCOW, RUSSIA - Media OutReach - 11 September 2023 - Metalloinvest, a pioneer of green…
MOSCOW, RUSSIA - Media OutReach - 11 September 2023 - Metalloinvest, a pioneer of green…
SHANGHAI--(BUSINESS WIRE)--The Shanghai office of international law firm Dorsey & Whitney has moved to a…
HONG KONG--(BUSINESS WIRE)--#insurance--Despite a sharp increase in catastrophe losses outside their home markets and a…
SolarWinds will showcase its product portfolio and speak on how integrated observability and service management…
ZUG, SWITZERLAND - Media OutReach - 11 September 2023 - pCloud, the leading platform in…
Today marks 10 years since the European Medicines Agency (EMA) approved the world’s first monoclonal…
Encouraging objective response rate of 52.4% was seen with ifinatamab deruxtecan in heavily pretreated patients…
An objective response rate of 29.8% was observed with patritumab deruxtecan in heavily pretreated patients…
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab with or without chemotherapy demonstrated objective response…
Medical professionals and social organizations call for increased awareness of pneumococcal threat and strengthened preventative…